ITPC regional links

ITPC NIS/CIS/Baltic
ITPC China

News Feeds

A Healthy Mind Can Help Fight HIV (HealthDay) [From]
NIAID CREATES HIV VACCINE DISCOVERY BRANCH TO PROMOTE SYNERGY BETWEEN BASIC HIV RESEARCHERS AND VACCINE DESIGNERS [From]
Study: Treating herpes doesn't prevent HIV (AP) [From]
PEPFAR game of chicken in Senate [From]
Quarter of Ethiopia AIDS patients have stopped drugs (Reuters) [From]
Cytheris Announces Publication of IL-7 Oncology Data in The Journal of Experimental Medicine [From]
HIV/AIDS Epidemic in Sub-Saharan Africa Should Be Classified as Disaster, Red Cross Report Says [From]
World Community Advisory Board (WOLRD CAB) candidates have been selected

  At the end of March, the World Community Advisory Board (World CAB) working group conducted a participant selection process. As a result, we are delighted to announce successful candidates below.

 

Aditi Sharma

India

Andy Agbein Kings

Senegal

Bob Huff

U.S.A.

Carlos Nicolas Garcia de Leon Moreno

Mexico

Dorothy Namutamba

Uganda

Gcebile Ndlovu

Swaziland

Gopar Kumar Nair

U.K.

Kajal Bhardwaj

India

Kostyantyn Lyezhentsev

Ukraine

Leena Menghaney

India

Maria Lorena Di Giano

Argentina

Mohammad Ismail

Pakistan

Muhinda Aaron

Uganda

Obatunde Oladapo

Nigeria

Raoul Fransen dos Santos

The Netherlands

Simao Cacumba Morais Faria

Angola

Snehansu Bhaduri

India

Vladimir Osin

Russia

Sudin Sherchan

Nepal

Asia Russell

U.S.A.

Kannikar Kijtiwatchakul

Thailand

Paul Kasonkomona

Zambia

Sanya Reid Smith

Malaysia

 

We’d like to express our gratitude to everyone who showed their interest in participating in this meeting by submitting  application to us. If you have specific issues regarding 2-line/ 3-line ARV drug treatment, generic formulations of AIDS medicines and  pediatric treatment you want to raise, kindly communicate with representative from your respective region (the participant list of this meeting with contact details can be download here) or post to ITPC global list serve prior to the meeting. Note that the WorldCAB meeting will take place from 22th  to 24th  April, 2008 in New Delhi, India.

 

The invited pharmaceutical companies that will be attending the meeting include Ranbaxy, Matrix and Aurobindo/Emcure (to be confirmed).

 

Objectives of the WorldCAB4:

  1. To build capacity among HIV+ leaders and advocates on drug development and access issues, particularly issues around access to generic formulations of AIDS medicines.
  2. To allow PLHIV leaders and advocates share and learn from each other about how to advocate for access to treatment.
  3. To build advocacy skills on issues related to access to essential medicines, including antiretroviral drugs, so that PLHIV leaders and advocates can be more effective in national advocacy efforts.
  4. A platform to engage the generic pharmaceutical industry on issues of shared concern in terms of access to AIDS drugs.
  5. To develop country specific strategies and action plans for greater access to 2nd and 3rd line ARV medicines

 

At this stage ITPC is arranging conference logistics for meeting participants. We’ll follow up with the outcomes of the meeting. If you have any concerns or questions, please don’t hesitate to contact ITPC Secretariat

 
<< Start < Prev 1 2 Next > End >>

Results 1 - 5 of 6
gawbanner.gif

Projects

bannersmall012.gif




bannersmall022.gif




cabbanner3.gif




Advocacy and Campaigns

Responses to ITPC sign-on letter

Dear Members of the International Treatment Preparedness Coalition, Thank you for your open letter of 17 December 2007 concerning the Scaling Up for Better Health (SUBH) plan. We welcome your...
+ Full Story

More Articles